Literature DB >> 1708171

Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro.

M Repetto1, J C Maziere, D Citadelle, R Dupuis, M Meier, S Biade, D Quiec, C Roux.   

Abstract

AY 9944 [trans-1,4-bis(2-chlorobenzylaminomethyl) cyclohexane dihydrochloride] is an amphiphilic cationic molecule. This chemical is an established inhibitor of cholesterol synthesis and is teratogenic in rats. The mechanisms of this teratogenicity remain to be clarified. This study used cultured rat whole embryos to ascertain whether AY 9944 had a direct effect on embryos, or whether its action was indirect, via the maternal cholesterol metabolism. Four experimental conditions were investigated: (A) controls; (B) 10 day untreated embryos were cultured in serum of treated rats; (C) 10 day untreated embryos were cultured in serum containing added AY 9944 (0-1,000 micrograms/ml); and (D) 10 day embryos from females treated on day 4 of gestation were cultured in normal serum. In group B there was no growth retardation; some slight nonspecific abnormalities were not significant. In group C, direct addition of AY 9944 to culture medium retarded growth and differentiation in a dose-dependent manner. No malformation was observed, but histological examinations showed numerous areas of cell necrosis, especially in the CNS. In group D, not only was growth retardation observed, but also characteristic malformations of AY 9944 teratogenesis, including pituitary agenesis. These results show that AY 9944 teratogenicity is initiated prior to day 10.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708171     DOI: 10.1002/tera.1420420605

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  6 in total

1.  Characterization of the biochemical abnormality in the Smith-Lemli-Opitz syndrome.

Authors:  A K Batta; G Salen
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

Review 2.  SHH pathway and cerebellar development.

Authors:  Catherine Vaillant; Denis Monard
Journal:  Cerebellum       Date:  2009-02-18       Impact factor: 3.847

Review 3.  Holoprosencephaly.

Authors:  Christèle Dubourg; Claude Bendavid; Laurent Pasquier; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Orphanet J Rare Dis       Date:  2007-02-02       Impact factor: 4.123

4.  Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion.

Authors:  Maarten F Bijlsma; C Arnold Spek; Danica Zivkovic; Sandra van de Water; Farhad Rezaee; Maikel P Peppelenbosch
Journal:  PLoS Biol       Date:  2006-07       Impact factor: 8.029

Review 5.  The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man.

Authors:  Maria Teresa Fiorenza; Piergiorgio La Rosa; Sonia Canterini; Robert P Erickson
Journal:  Cerebellum       Date:  2022-01-18       Impact factor: 3.648

6.  Cyclopia: a rare condition with unusual presentation - a case report.

Authors:  Ghassan Sa Salama; Mahmoud Af Kaabneh; Mohamed K Al-Raqad; Ibrahim Mh Al-Abdallah; Ayoub Ga Shakkoury; Ruba Aa Halaseh
Journal:  Clin Med Insights Pediatr       Date:  2015-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.